{"related:1H9qem3oBucJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5":[{"title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene","url":"https://science.sciencemag.org/content/235/4785/177.abstract","authors":["DJ Slamon","DJ Slamon GM Clark","DJ Slamon GM Clark SG Wong","DJ Slamon GM Clark SG Wong WJ Levin…"],"year":1987,"numCitations":13223,"pdf":"https://www.researchgate.net/profile/Gary_Clark/publication/19364043_Slamon_DJ_Clark_GM_Wong_SG_Levin_WJ_Ullrich_A_McGuire_WLHuman_breast_cancer_correlation_of_relapse_and_survival_with_amplification_of_the_HER-2neu_oncogene_Science_Wash_DC_235_177-182/links/0046352b85f241a532000000.pdf","citationUrl":"http://scholar.google.com/scholar?cites=16647248629524496340&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:1H9qem3oBucJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16647248629524496340&hl=en&as_sdt=0,5","publication":"science.sciencemag.org","p":1,"exp":1596885628066},{"title":"Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer","url":"https://science.sciencemag.org/content/244/4905/707.abstract","authors":["DJ Slamon","DJ Slamon W Godolphin","DJ Slamon W Godolphin LA Jones","DJ Slamon W Godolphin LA Jones JA Holt…"],"year":1989,"numCitations":8016,"pdf":"https://www.researchgate.net/profile/William_Godolphin/publication/20686289_Studies_of_the_HER-2neu_proto-oncogene_in_human_breast_and_ovaian_cancer/links/565f907808aeafc2aaca8d50.pdf","citationUrl":"http://scholar.google.com/scholar?cites=3021817142696578717&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:nY6dVq6m7ykJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3021817142696578717&hl=en&as_sdt=0,5","publication":"science.sciencemag.org"},{"title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","url":"https://www.nejm.org/doi/full/10.1056/NEJM200103153441101","authors":["DJ Slamon","DJ Slamon B Leyland"],"year":2001,"numCitations":11578,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJM200103153441101","citationUrl":"http://scholar.google.com/scholar?cites=11639266862263687873&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:wdozM4v7hqEJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11639266862263687873&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa052122","authors":["EH Romond","EH Romond EA Perez","EH Romond EA Perez J Bryant…"],"year":2005,"numCitations":5935,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa052122","citationUrl":"http://scholar.google.com/scholar?cites=11297359856054390435&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:o07h3-5IyJwJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11297359856054390435&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer …","url":"http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.981.1131&rep=rep1&type=pdf","authors":["MA Cobleigh","MA Cobleigh CL Vogel","MA Cobleigh CL Vogel D Tripathy","MA Cobleigh CL Vogel D Tripathy NJ Robert…"],"year":1999,"numCitations":3257,"pdf":"http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.981.1131&rep=rep1&type=pdf","citationUrl":"http://scholar.google.com/scholar?cites=13902576998117423717&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ZTpO6x7g78AJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13902576998117423717&hl=en&as_sdt=0,5","publication":"Citeseer"},{"title":"Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer","url":"https://www.nejm.org/doi/full/10.1056/nejmoa052306","authors":["MJ Piccart"],"year":2005,"numCitations":5369,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa052306","citationUrl":"http://scholar.google.com/scholar?cites=1796034903430917809&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:se4zlzrM7BgJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1796034903430917809&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"},{"title":"Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer","url":"http://www.quantason.com/pdf/HER_2_and_Trastuzumab.pdf","authors":["CL Vogel","CL Vogel MA Cobleigh","CL Vogel MA Cobleigh D Tripathy…"],"year":2002,"numCitations":3567,"pdf":"http://www.quantason.com/pdf/HER_2_and_Trastuzumab.pdf","citationUrl":"http://scholar.google.com/scholar?cites=18217907854524590742&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:lqq8y6sC0_wJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=18217907854524590742&hl=en&as_sdt=0,5","publication":"quantason.com"},{"title":"Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene","url":"https://science.sciencemag.org/content/230/4730/1132.abstract","authors":["L Coussens","L Coussens TL Yang"],"year":1985,"numCitations":2297,"citationUrl":"http://scholar.google.com/scholar?cites=7774117500800944608&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:4Eljja0242sJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7774117500800944608&hl=en&as_sdt=0,5","publication":"science.sciencemag.org"},{"title":"Untangling the ErbB signalling network","url":"https://www.nature.com/articles/35052073","authors":["Y Yarden","Y Yarden MX Sliwkowski"],"year":2001,"numCitations":7203,"pdf":"http://www.cellsignet.com/learn/papers/Yarden.pdf","citationUrl":"http://scholar.google.com/scholar?cites=4220468693144107513&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:-fmCWOodkjoJ:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4220468693144107513&hl=en&as_sdt=0,5","publication":"nature.com"},{"title":"Lapatinib plus capecitabine for HER2-positive advanced breast cancer","url":"https://www.nejm.org/doi/full/10.1056/nejmoa064320","authors":["CE Geyer","CE Geyer J Forster","CE Geyer J Forster D Lindquist","CE Geyer J Forster D Lindquist S Chan…"],"year":2006,"numCitations":3427,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa064320","citationUrl":"http://scholar.google.com/scholar?cites=6727213605667548655&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:7y39zSHdW10J:scholar.google.com/&scioq=&hl=en&as_sdt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=6727213605667548655&hl=en&as_sdt=0,5","publication":"Mass Medical Soc"}]}